Locations:
April 2, 2021/Neurosciences/Podcast

Treating Spinal Cord Injury: More Than Addressing Motor and Sensory Function (Podcast)

The latest advances in care, technology and research

Managing patients with spinal cord injury requires more than addressing the loss of motor and sensory function. Patients with paraplegia or tetraplegia can have a host of autonomic dysfunctions involving their bowel, bladder, lungs, skin, endocrine system and other organs, not to mention behavioral health issues like depression and post-traumatic stress disorder.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“These patients need ongoing care for each organ system for the rest of their lives,” says physiatrist Gregory Nemunaitis, MD, Medical Director of Spinal Cord Injury Rehabilitation at Cleveland Clinic.

Dr. Nemunaitis discusses the latest advances in the management of spinal cord injuries in the newest episode of Cleveland Clinic’s Neuro Pathways podcast. He touches on:

  • How early interventions can improve short- and long-term issues for patients
  • The role of steroids and stem cells
  • The latest innovations in technology and assistive devices for patients
  • Enhancing motor function with direct-current stimulation of the brain
  • Common causes of death in patients with spinal cord injury

Click the podcast player above to listen to the episode now, or read on for a few short edited excerpts. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpts from the podcast

Dr. Nemunaitis: Twenty years ago, if you had a spinal cord injury and you couldn’t drive, couldn’t walk, couldn’t ride a bike, it really put you behind in life. The redesign of wheelchairs and assistive devices for driving, for standing and for walking has been remarkable and has really improved the health and wellness and participation of our patients with spinal cord injury.

Dr. Nemunaitis: A lot of studies, including STASCIS [Surgical Timing in Acute Spinal Cord Injury Study], looked at early surgery and showed improved outcomes if people went to the OR within the first 24 hours. There also have been studies on early rehabilitation. Instead of starting rehab once the patient leaves the hospital, you start it right there in the acute care hospital. Then post-acute rehabilitation therapies can help enhance function.

Advertisement

Some interesting surgical procedures — with nerve transfers, tendon transfers and electrical stimulation — have enhanced function significantly for these people as well.

We did an interesting study in 2018 using direct-current stimulation of the brain to enhance motor function of people with spinal cord injury. It was a small study with eight patients, but it clearly showed some improvement in motor function, along with therapy. At this time, we are involved in a phase 2 clinical trial with three different centers, looking at a larger volume of patients to assess the effectiveness of direct brain stimulation.

Advertisement

Related Articles

woman in lab holding two vials filled with liquids
October 19, 2026/Neurosciences/Brain Health

CSF and Plasma Analytes Reveal Early Clues to Alzheimer’s Development

Inflammatory protein eotaxin-1 may be a marker of future cognitive decline

headshots of Drs. Lilly and Barron

Early Mobilization in Neuro Intensive Care (Podcast)

Therapists and physicians collaborate to get medically stable patients moving

23-NEU-3627359-CQD-Hero-650×450

6 Things to Know About the New Home of Our Neurological Institute

Designed for digitization, distance health, discovery and more

illustration of a bright clinical room with clinicians inside

Inside Our Neurological Institute’s Next-Generation Advanced Therapeutics Space

Combining customized care, research capabilities and flexibility for the future

stylized illustration of human brain made up of cogs and wheels
October 9, 2026/Neurosciences/Brain Health

How Alzheimer’s Disease Studies Need to Evolve in the Targeted Therapy Era

Leading investigators outline a new roadmap for clinical trials and observational research

Older man tending to houseplants

TEMPO-2 Trial Shows Promise for Tavapadon in Newly Diagnosed Parkinson’s Disease

The selective D1/D5 dopamine agonist provides symptom relief and improves daily function.

illustration of human brain with swirls of activity inside it
September 23, 2026/Neurosciences/Brain Health

Cleveland ADRC Renewal Boosts Research Into Alzheimer’s Progression

5-year funding award supports cohort expansion and deep phenotyping of AD and related dementias

young man meditating on a sofa
September 21, 2026/Neurosciences/Epilepsy

Lifestyle Interventions Show Promise as Adjunctive Epilepsy Management

Highest response rates seen with stress-lowering techniques like yoga, meditation and mindfulness

Ad